BY PHILIP MADSEN
-
Novo Nordisk hires headhunter to find CEO replacement
The talent scout charged with locating a brand-new chief executive officer has actually formerly aided the Novo Nordisk Team discover its present chief executive officer of Novo Ho…
-
Security advisor on Novo Nordisk in Iran: They are ready to evacuate very quickly
According to a Danish safety and security expert, Novo Nordisk has actually involved a number of safety and security firms in connection with the existing dispute in the center Eas…
-
Security advisor on Novo Nordisk in Iran: They are ready to evacuate very quickly
According to a Danish security advisor, Novo Nordisk has engaged several security companies in relation to the current conflict in the Middle East.
-
Caught up in major conflict: Novo Nordisk continues production in Iran “without interruption”
Novo Nordisk has actually taken “essential precaution” to secure the business’s workers in Iran, the business’s Iranian subsidiary claims in a declaration.
-
AstraZeneca signs another billion-dollar deal with Chinese CSPC Pharmaceuticals
The Chinese biotech company will certainly be paid USD 110m in advance, with later settlements on advancement and sales turning points in exces of USD 5bn.
-
Life science investors risk groupthink: Create self-fulfilling prophecies with current trend
Life scientific research endeavor funds worth suspicion and instinct over organized procedures that can gauge and consider business on an extra unbiased basis, claims Lundbeckfonde…
-
AstraZeneca signs another billion-dollar deal with Chinese CSPC Pharmaceuticals
The Chinese biotech firm will be paid USD 110m upfront, with later payments on development and sales milestones in exces of USD 5bn.
-
FDA launches new program for fast-track approval of essential medicines
According to the company, the program will certainly have the ability to reduce the authorization procedure for chosen medications from 10-12 months to simply 1 or 2 months.
-
Life science investors risk groupthink: Create self-fulfilling prophecies with current trend
Life science venture funds value gut feeling and intuition over systematic processes that can measure and weigh companies on a more objective basis, says Lundbeckfonden Biocapital.
-
Healthcare fund targets Nordic companies after raising USD 795m
The funds will certainly be invested in fully grown Nordic firms in the pharmaceutical and health care market, claims companion. Nevertheless, biotech firms need to not anticipate …
